{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"leukoencephalopathy-acute-reversible-with-increased-urinary-alpha-ketoglutarate","columns":[{"gene":"","key":"population-6e79b606705d64393bc7","label":"Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate","mondoId":"MONDO:0032716","onsetQualifier":null,"originColumnKey":"MONDO:0032716/OMIM:618384","originalViews":[{"key":"MONDO:0032716/OMIM:618384","label":"Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate","scopeLabel":"OMIM:618384","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["1a49f6c3b4954648a74cc3bfb2b3354254a4a9ca1c154f006cad4d9b538c040f","3fcdb4a8d2eaf8e3e1d01788caca51d3d4bc28099a54897edce949fc031ab1c3","423213a527909ece384967901238f0558d7126aedbcce0c95a17936841fdddcf","4306926e56548a134813df760ad9f6fe6a45c49a0068407c182c0cb975c5c23c","53234bb1efb1d0f83968d2fd6c2e591d2edf703814375f7a8a559cf829d4ce57","634154f6ed08f98bb66d481c74f9f7897d8be2b65ea1967c024daad2bdefd44c","7498b3351437916161c8b466f09dfbcc055faa687e3b86f8d48c01b847ce7000","75de04a6092744fd8bcebed8ccdab1b4f64bf5200dc193248efa892b5570398f","8c2ecb7f2ddda9f4ae134a329a8d7e3383cb7be325675e096d819f152a430b20","a1dc554c73121f8ae97b2fc1dca3d4758d97fceaa48ae0ccf3f32420ab390fed","b588d22d32accff4fc4b0da30e83db21bbdf2c75d0f4fb98db51edc08b11480c","be2732e1a8e5ebc5295c6b3ba266f44313c9585bb7e0f1d63d535bde1bff5f0a","c8ba2a974d689e4abc20a2e1cd0e4b80b8cca38bf9f06c8fb3a49b089c320ddd","cfbcb0e76aa745f5f4d33970d35d7e105035376c6798e6e96fc1c6508b3029ca","e9275794122574bff7707d8c9c70e4c6c57eeceea093b9f7a16bb3cf2258ad5f"],"recordQualifiers":{},"scopeLabel":"OMIM:618384","sourceIds":["OMIM:618384"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-6e79b606705d64393bc7"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0002500","HP:0001251","HP:0001272","HP:0012229","HP:0002329","HP:0001260","HP:0001310"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":15,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":15,"sourceGroups":{"published":15}},"features":[{"hpoId":"HP:0002500","label":"Abnormal cerebral white matter morphology","primary":true},{"hpoId":"HP:0001251","label":"Ataxia","primary":true},{"hpoId":"HP:0001272","label":"Cerebellar atrophy","primary":true},{"hpoId":"HP:0012229","label":"CSF pleocytosis","primary":true},{"hpoId":"HP:0002329","label":"Drowsiness","primary":true},{"hpoId":"HP:0001260","label":"Dysarthria","primary":true},{"hpoId":"HP:0001310","label":"Dysmetria","primary":true},{"hpoId":"HP:6000468","label":"Elevated CSF alpha-ketoglutarate concentration","primary":false},{"hpoId":"HP:0034649","label":"Elevated urine N-acetylaspartic acid level","primary":false},{"hpoId":"HP:0002373","label":"Febrile seizure (within the age range of 3 months to 6 years)","primary":false},{"hpoId":"HP:0001290","label":"Generalized hypotonia","primary":false},{"hpoId":"HP:0002490","label":"Increased CSF lactate","primary":false},{"hpoId":"HP:0012402","label":"Increased urine alpha-ketoglutarate concentration","primary":false},{"hpoId":"HP:0033092","label":"Increased urine succinate level","primary":false},{"hpoId":"HP:0002344","label":"Progressive neurologic deterioration","primary":false}],"ledeHtml":"","mondoId":"MONDO:0032716","node":{"canonicalSlug":"leukoencephalopathy-acute-reversible-with-increased-urinary-alpha-ketoglutarate","comparisons":[{"documentSha256":"1938e14b1fcaa91a192455c6ee714a1c547b8e8273de0a60d7e223091ccea916","key":"legacy-leukoencephalopathy-acute-reversible-with-increased-urinary-alpha-ketoglutarate","kind":"legacy","label":"leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate","memberIds":["MONDO:0032716"],"mondoId":"MONDO:0032716","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/leukoencephalopathy-acute-reversible-with-increased-urinary-alpha-ketoglutarate.1938e14b1fcaa91a192455c6ee714a1c547b8e8273de0a60d7e223091ccea916.json"}],"contexts":[],"lifecycle":"active","narrative":null,"ownColumnKeys":["population-6e79b606705d64393bc7"],"publication":"published","relationships":[{"kind":"parent","label":"hereditary disease","mondoId":"MONDO:0003847","slug":null},{"kind":"parent","label":"acute disease","mondoId":"MONDO:0020683","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/18035"}],"translation":"pending"},"records":[{"frequencyKind":"count","key":"1a49f6c3b4954648a74cc3bfb2b3354254a4a9ca1c154f006cad4d9b538c040f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:618384","disease_name":"Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0001272","is_excluded":false,"label":"Cerebellar atrophy","onset_id":null,"reference":"PMID:30635937","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"3fcdb4a8d2eaf8e3e1d01788caca51d3d4bc28099a54897edce949fc031ab1c3","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:618384","disease_name":"Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0002373","is_excluded":false,"label":"Febrile seizure (within the age range of 3 months to 6 years)","onset_id":null,"reference":"PMID:30635937","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"423213a527909ece384967901238f0558d7126aedbcce0c95a17936841fdddcf","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:618384","disease_name":"Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0002500","is_excluded":false,"label":"Abnormal cerebral white matter morphology","onset_id":null,"reference":"PMID:30635937","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"4306926e56548a134813df760ad9f6fe6a45c49a0068407c182c0cb975c5c23c","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:618384","disease_name":"Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0012402","is_excluded":false,"label":"Increased urine alpha-ketoglutarate concentration","onset_id":null,"reference":"PMID:30635937","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"53234bb1efb1d0f83968d2fd6c2e591d2edf703814375f7a8a559cf829d4ce57","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:618384","disease_name":"Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:6000468","is_excluded":false,"label":"Elevated CSF alpha-ketoglutarate concentration","onset_id":null,"reference":"PMID:30635937","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"634154f6ed08f98bb66d481c74f9f7897d8be2b65ea1967c024daad2bdefd44c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:618384","disease_name":"Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0002344","is_excluded":false,"label":"Progressive neurologic deterioration","onset_id":null,"reference":"PMID:30635937","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"7498b3351437916161c8b466f09dfbcc055faa687e3b86f8d48c01b847ce7000","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:618384","disease_name":"Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0001260","is_excluded":false,"label":"Dysarthria","onset_id":null,"reference":"PMID:30635937","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"75de04a6092744fd8bcebed8ccdab1b4f64bf5200dc193248efa892b5570398f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:618384","disease_name":"Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0012229","is_excluded":false,"label":"CSF pleocytosis","onset_id":null,"reference":"PMID:30635937","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"8c2ecb7f2ddda9f4ae134a329a8d7e3383cb7be325675e096d819f152a430b20","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:618384","disease_name":"Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0001251","is_excluded":false,"label":"Ataxia","onset_id":null,"reference":"PMID:30635937","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"a1dc554c73121f8ae97b2fc1dca3d4758d97fceaa48ae0ccf3f32420ab390fed","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:618384","disease_name":"Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0001310","is_excluded":false,"label":"Dysmetria","onset_id":null,"reference":"PMID:30635937","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"b588d22d32accff4fc4b0da30e83db21bbdf2c75d0f4fb98db51edc08b11480c","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:618384","disease_name":"Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0001290","is_excluded":false,"label":"Generalized hypotonia","onset_id":null,"reference":"PMID:30635937","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"be2732e1a8e5ebc5295c6b3ba266f44313c9585bb7e0f1d63d535bde1bff5f0a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:618384","disease_name":"Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0002329","is_excluded":false,"label":"Drowsiness","onset_id":null,"reference":"PMID:30635937","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"c8ba2a974d689e4abc20a2e1cd0e4b80b8cca38bf9f06c8fb3a49b089c320ddd","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:618384","disease_name":"Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0033092","is_excluded":false,"label":"Increased urine succinate level","onset_id":null,"reference":"PMID:30635937","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"cfbcb0e76aa745f5f4d33970d35d7e105035376c6798e6e96fc1c6508b3029ca","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:618384","disease_name":"Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0034649","is_excluded":false,"label":"Elevated urine N-acetylaspartic acid level","onset_id":null,"reference":"PMID:30635937","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"e9275794122574bff7707d8c9c70e4c6c57eeceea093b9f7a16bb3cf2258ad5f","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:618384","disease_name":"Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0002490","is_excluded":false,"label":"Increased CSF lactate","onset_id":null,"reference":"PMID:30635937","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[],"sharedSources":[],"slug":"leukoencephalopathy-acute-reversible-with-increased-urinary-alpha-ketoglutarate","sourceDocuments":[],"sourceNote":"","synonyms":["acute reversible leukoencephalopathy due to SLC13A3 deficiency","acute reversible leukoencephalopathy due to sodium-dependent dicarboxylate transporter deficiency","acute reversible leukoencephalopathy with increased urinary alpha-ketoglutarate","ARLIAK"],"takeawayHtml":"","title":"leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate"},"schemaVersion":1}
